Sensory polyneuropathy associated with paclitaxel-eluting coronary stent

Abstract Paclitaxel is a microtubule-stabilizing chemotherapeutic agent used in ovarian and breast cancer; its principal adverse effect is sensory neuropathy. We describe the occurrence of sensory polyneuropathy after multiple paclitaxel-eluting stents in a patient who may have sub-clinical Sjogrens...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the neurological sciences 2009-09, Vol.284 (1), p.175-176
Main Authors: Srinivasan, Jayashri, Jones, H. Royden
Format: Article
Language:English
Subjects:
Aged
Angina, Unstable - complications
Angina, Unstable - drug therapy
Angina, Unstable - therapy
Angioplasty, Balloon
Biological and medical sciences
Coronary Restenosis - prevention & control
Coronary stent
Cranial nerves. Spinal roots. Peripheral nerves. Autonomic nervous system. Gustation. Olfaction
Disease Susceptibility
Drug-Eluting Stents - adverse effects
Humans
Male
Medical sciences
Nervous system (semeiology, syndromes)
Neural Conduction
Neurology
Neuropathy
Paclitaxel
Paclitaxel - administration & dosage
Paclitaxel - adverse effects
Paresthesia - chemically induced
Polyneuropathies - chemically induced
Recurrence
Sensation Disorders - chemically induced
Sjogren's Syndrome - complications
Sjogrens syndrome
Toxicity
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Paclitaxel is a microtubule-stabilizing chemotherapeutic agent used in ovarian and breast cancer; its principal adverse effect is sensory neuropathy. We describe the occurrence of sensory polyneuropathy after multiple paclitaxel-eluting stents in a patient who may have sub-clinical Sjogrens syndrome.
ISSN:0022-510X
1878-5883
DOI:10.1016/j.jns.2009.02.342